The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMMC.L Regulatory News (MMC)

  • There is currently no data for MMC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed disposal and trading update

23 Nov 2015 07:00

RNS Number : 5436G
Management Consulting Group PLC
23 November 2015
 



23 November 2015

 

Management Consulting Group PLC ("MCG or "the Company")

Proposed disposal of certain operations of Kurt Salmon and trading update

Highlights

· MCG is in advanced discussions for the sale of certain operations of Kurt Salmon, in France and other geographies, to Solucom SA ("Solucom")

· Following completion of a mandatory consultation with the respective Works Councils of MCG and Solucom, the parties expect to finalise negotiations and thereafter enter into a binding agreement

· The proposed disposal is expected to realise gross cash proceeds of approximately £60 million, enabling the Group to repay existing indebtedness

· The proposed disposal represents an attractive value for shareholders, the proposed gross consideration representing approximately 80% of the Group's current market capitalisation

· The transaction will rebalance the Group's portfolio in geographic terms, reducing exposure to the French market and refocusing MCG on growth opportunities in North America and Asia

· The remaining Kurt Salmon business will benefit from tight focus on the retail and consumer goods industry vertical where it is a market leader, together with the US healthcare business

· The Disposal will not be earnings accretive

· Accounting for the IFRS loss on sale will have a significant negative impact on the Company's distributable reserves and consequently, if the disposal proceeds, the Company will not be in a position to pay the interim dividend of 0.23 pence per share which was announced on 31 July 2015

· MCG today also announces a trading update, reporting deterioration in the outlook for Alexander Proudfoot for 2015 and continuing positive progress in Kurt Salmon.

MCG today announces that it is in advanced discussions with Solucom for the sale of certain operations of Kurt Salmon (the "Target Business"), comprising the Kurt Salmon businesses in France, Belgium, Luxembourg, Switzerland and Morocco, together with certain related operations in the United States, to Solucom, for a total proposed cash consideration of approximately €84 million (equivalent to approximately £60 million) payable on completion of the sale (the "Disposal"). 

The Kurt Salmon business retained by MCG will continue to serve international retail and consumer goods clients on a global basis, including through the established Kurt Salmon businesses in Germany and the United Kingdom which are not part of the Target Business subject to the proposed Disposal, alongside the operations in North America and Asia. MCG will also retain the Kurt Salmon healthcare practice based in the US.

As required under French law, a mandatory consultation is in progress with the respective Works Councils of Kurt Salmon and Solucom in relation to the Disposal (the "Works Council Consultations"). Following completion of the Works Council Consultations MCG and Solucom expect to finalise negotiations and thereafter enter into a binding agreement. A further announcement will be made in respect to this process in due course.

The Disposal, if entered into, is of sufficient size relative to the Group to constitute a Class 1 transaction for MCG under the Listing Rules and will therefore be conditional upon, amongst other things, the passing of a resolution (the "Disposal Resolution") approving the Disposal by Shareholders at a general meeting (the "General Meeting"). The Disposal would also be conditional upon:

(i) there having been no material adverse change in relation to staff retention rates and current year forecast operating results of the Target Business from the date of entering into definitive agreements in relation to the Disposal; and

(ii) the French Anti-trust Authority (Autorité de la Concurrence) approving the Disposal.

MCG will use the expected net proceeds of approximately €82 million (equivalent to approximately £58.5 million, after estimated transaction costs of £1.5 million), to repay the Group's net bank indebtedness under the Company's Revolving Facility, which is expected to be approximately £50 million at Completion, and will retain the remaining net proceeds for general corporate purposes.

The purchase price is based on an agreed enterprise value for the Target Business of €98.5 million. The proposed gross cash proceeds of approximately €84 million (equivalent to approximately £60 million), (which will be subject to post-closing adjustments relating to amounts of debt, other debt like items, the appropriate level of existing provisions, cash and working capital at completion of the Disposal) represent approximately 80% of the Group's market capitalisation. By comparison, the revenue and profit before tax of the Target Business for the year ended 31 December 2014 represented approximately 40% of the Group's revenue and 38% of the Group's profit before tax for that year. The Target Business had total assets of £25.9 million (Group: £334.8 million) as at 30 June 2015 (unaudited) and generated profit before tax of £1.9 million for the year ended 31 December 2014.

The Disposal is expected to generate a one-off IFRS loss on sale of approximately £50 million, principally as a result of the write-off of goodwill held in the consolidated balance sheet of the Group which is allocated to the Target Business. The accounting impact of this IFRS loss will have a significant negative impact on the Company's distributable reserves and consequently, if the disposal proceeds, the Company will not be in a position to pay the interim dividend of 0.23 pence per share, which was announced on 31 July 2015 and was expected to be paid on 6 January 2016. The Company will review the position after completion of the Disposal and it is likely that it will, as soon as reasonably practicable, seek to implement a reconstruction of reserves to enable dividend payments to be resumed. The Board will consider future dividends once this process is complete.

Trading update

The Board issued a trading update with its Interim Results statement on 31 July 2015, noting that Alexander Proudfoot was likely to deliver weaker third quarter revenues and that the outcome for the year as a whole for that business remained uncertain and would depend on the rate of order input in the coming months. Alexander Proudfoot's performance in the third quarter, as expected, was disappointing, including in the North American operations which had performed well in the first half. The order intake in the last four months has been weak and the Board does not now expect a significant improvement in performance over the rest of 2015. It is clear that reduced demand from natural resources' clients has contributed to this weakness, with revenues from this sector so far this year being approximately 40% lower than the same time last year. Action is being taken to accelerate change in the underperforming operations, in Europe and Africa in particular, which will involve some restructuring initiatives. However, the outlook for Alexander Proudfoot for 2015 as a whole has deteriorated from the position set out in the Interim Results statement and the Board currently expects that Alexander Proudfoot will deliver second half revenues in 2015 which are significantly lower than those in the first half of the year, and an operating loss for the year as a whole.

In the Interim Statement the Group reported net indebtedness of £41.7 million at 30 June 2015. As a result of result of weakness in Alexander Proudfoot the level of net indebtedness is currently higher than the half year position.

 

As noted in the Interim Statement, Kurt Salmon's North American business, focused on the US retail and consumer goods practice, reported slightly lower year on year revenues and operating profit margins in the first half, and this continued into the third quarter. Nevertheless we continue to see healthy demand from US retail sector clients and the Board expects that the broadly positive underlying trends in the Kurt Salmon business will continue to apply over the remainder of the financial year and into 2016. In the other geographies which form part of the Kurt Salmon business that will retained by MCG, the retail and consumer goods and healthcare practices have performed in line with expectations.

In relation to the Target Business, Kurt Salmon delivered an improved performance in its French business in the first half of 2015 and this positive trend has continued. The signs of improved confidence in the French market that were evident in the first half have continued to drive demand for Kurt Salmon's consulting services and we expect this positive momentum to continue during the remainder of 2015 and into 2016. In the other geographies which form the rest of the Target Business, performance has been in line with our expectations.

Alan Barber, Chairman of MCG, commented:

"The proposed disposal will significantly reduce Group indebtedness and create a business with a more balanced portfolio in geographic terms, focused on growth markets. The recent performance of Alexander Proudfoot has been disappointing, but the proposed disposal will enable the Group to continue to build a firm growth platform to support its recovery. The retained Kurt Salmon business will benefit from a tight focus on two industry verticals where the business has a strong position. We believe that the proposed transaction is firmly in shareholders' interests and will position MCG to concentrate its effort and resources on the businesses which are being retained."

 

Enquiries:

For further information please contact:

MCG

Tel: +44 20 7710 5000

Nick Stagg, Chief Executive

 

Chris Povey, Group Finance Director

 

 

 

FTI Consulting

Tel: +44 20 3727 1000

Ben Atwell

 

 

Notes to editors:

MCG (MMC.L) provides professional services across a wide range of industries and sectors. It comprises two independently managed practices: Alexander Proudfoot and Kurt Salmon. Alexander Proudfoot develops and implements operational improvements to its clients to increase productivity and reduce costs. Kurt Salmon provides consultancy services to a wide range of industries in both the private and public sectors. Alexander Proudfoot is not affected by the Disposal. The Target Business largely comprises Kurt Salmon businesses in France, Belgium, Luxembourg, Switzerland and Morocco, together with certain related operations in the United States. The Kurt Salmon business which will be retained by MCG following the Disposal comprises the international consulting practice focusing on clients in the retail and consumer goods sectors, and currently principally operating in the United States, Canada, the United Kingdom, Germany, Japan and China, and a healthcare consulting practice operating principally in the United States. Kurt Salmon is an established international brand and a leading management consulting firm addressing clients in the retail and consumer goods sector. The Kurt Salmon business which will be retained by MCG represented 47% of the revenues of Kurt Salmon as a whole in the first half of 2015.

Solucom is a leading French-based consulting business, with its principal operations in France.

For further information, visit www.mcgplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBXLBLEFFXFBQ
Date   Source Headline
17th Jun 20205:30 pmRNSManagement Consulting Group
26th May 20201:24 pmRNSResult of AGM
21st May 20209:56 amRNSHolding(s) in Company
20th May 202012:06 pmRNSHolding(s) in Company
20th May 202012:05 pmRNSHolding(s) in Company
12th May 20204:41 pmRNSSecond Price Monitoring Extn
12th May 20204:35 pmRNSPrice Monitoring Extension
1st May 20207:00 amRNSNotice of AGM and Publication of Circular
27th Apr 20207:00 amRNSFinal Results
16th Apr 20207:00 amRNSUpdate on current trading and impact of COVID-19
18th Mar 20204:43 pmRNSSecond Price Monitoring Extn
18th Mar 20204:39 pmRNSPrice Monitoring Extension
4th Feb 202012:07 pmRNSSecond Price Monitoring Extn
4th Feb 202012:02 pmRNSPrice Monitoring Extension
8th Jan 20204:41 pmRNSSecond Price Monitoring Extn
8th Jan 20204:35 pmRNSPrice Monitoring Extension
16th Dec 20197:00 amRNSDirectorate Change
10th Dec 20193:48 pmRNSHolding(s) in Company
5th Dec 20193:52 pmRNSHolding(s) in Company
4th Nov 20194:41 pmRNSSecond Price Monitoring Extn
4th Nov 20194:36 pmRNSPrice Monitoring Extension
20th Sep 20197:00 amRNSInterim Results
25th Jun 201911:44 amRNSHolding(s) in Company
18th Jun 20194:40 pmRNSResult of AGM
26th Apr 20195:47 pmRNSHolding(s) in Company
15th Mar 20197:00 amRNSPreliminary Results
31st Jan 20194:41 pmRNSSecond Price Monitoring Extn
31st Jan 20194:36 pmRNSPrice Monitoring Extension
24th Jan 20199:07 amRNSHolding(s) in Company
23rd Jan 201911:06 amRNSHolding(s) in Company
11th Jan 20191:05 pmRNSDirector/PDMR Shareholding
28th Dec 20184:36 pmRNSPrice Monitoring Extension
6th Dec 20184:40 pmRNSSecond Price Monitoring Extn
6th Dec 20184:35 pmRNSPrice Monitoring Extension
27th Nov 20187:00 amRNSUpdate on the Kurt Salmon escrow funds
21st Nov 20184:41 pmRNSSecond Price Monitoring Extn
21st Nov 20184:35 pmRNSPrice Monitoring Extension
9th Nov 20184:40 pmRNSSecond Price Monitoring Extn
9th Nov 20184:35 pmRNSPrice Monitoring Extension
2nd Nov 20184:40 pmRNSSecond Price Monitoring Extn
2nd Nov 20184:35 pmRNSPrice Monitoring Extension
1st Oct 20181:28 pmRNSUpdate on the Kurt Salmon escrow funds
17th Sep 201811:19 amRNSDirector Declaration
17th Aug 20184:53 pmRNSHolding(s) in Company
13th Aug 20187:00 amRNSHalf-year Report
9th Aug 20184:40 pmRNSSecond Price Monitoring Extn
9th Aug 20184:35 pmRNSPrice Monitoring Extension
3rd Aug 20187:00 amRNSUpdate on the Kurt Salmon escrow funds
24th Jul 201812:55 pmRNSHolding(s) in Company
23rd Jul 20183:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.